{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:30:12Z","timestamp":1791948612277,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5K23DA058751-02"],"award-info":[{"award-number":["5K23DA058751-02"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R34DA057609-01"],"award-info":[{"award-number":["1R34DA057609-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Initiation of buprenorphine for treatment of opioid use disorder (OUD) in acute care settings improves access and outcomes, however patients who use methamphetamine are less likely to link to ongoing treatment. We describe the intervention and design from a pilot randomized controlled trial of an intervention to increase linkage to and retention in outpatient buprenorphine services for patients with OUD and methamphetamine use who initiate buprenorphine in the hospital.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study is a two-arm pilot randomized controlled trial (N\u2009=\u200940) comparing the mHealth Incentivized Adherence Plus Patient Navigation (MIAPP) intervention to treatment as usual. Development of the MIAPP intervention was guided by the information-motivation-behavioral skills model and combines financial rewards via mobile health-based adherence monitoring with the \u201chuman touch\u201d of a patient navigator. Participants receive financial incentives for submitting videos of themselves taking buprenorphine via smartphone. The Patient Navigator reviews videos and provides treatment adherence coaching, care coordination and motivational enhancement. The intervention is introduced prior to hospital discharge and is offered for 30\u00a0days. The primary outcome is linkage to outpatient buprenorphine care within 30\u00a0days of hospital discharge. Secondary outcomes include retention on buprenorphine 90\u00a0days post discharge, hospital readmissions, and past 30-day methamphetamine use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>Interventions are needed to increase linkage and retention to outpatient buprenorphine among hospitalized patients with OUD, especially for people who co-use methamphetamine. We will examine the MIAPP intervention to improve buprenorphine adherence and linkage to outpatient treatment in a pilot randomized controlled trial which will provide valuable insights about research approaches for hospitalized patients with substance use disorder.<\/jats:p>\n            <jats:p>\n              <jats:italic>Trial registration number<\/jats:italic>: NCT06027814. Date of Initial Release: 08\/30\/2023. Protocol Version: 03\/21\/2024.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13722-025-00538-1","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T14:53:35Z","timestamp":1738162415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial\u00a0to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder"],"prefix":"10.1186","volume":"20","clinical-trial-number":[{"clinical-trial-number":"nct06027814","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Elenore P.","family":"Bhatraju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin N.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Gojic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Iles-Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph O.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Samet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Hallgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith I.","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"538_CR1","unstructured":"Ahmad F, Rossen L, Sutton P. Provisional drug overdose death counts: National Center for Health Statistics; 2021 updated May 12, 2021. Available from: https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm."},{"key":"538_CR2","unstructured":"Mann B. Drug Overdose Deaths Spiked To 88,000 During The Pandemic, White House Says [Internet]. National Public Radio2021. Available from: https:\/\/www.npr.org\/2021\/04\/01\/983414684\/white-house-says-drug-overdose-deaths-spiked-to-88-000-during-the-pandemic."},{"issue":"50","key":"538_CR3","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","volume":"70","author":"J O'Donnell","year":"2021","unstructured":"O\u2019Donnell J, Tanz LJ, Gladden RM, Davis NL, Bitting J. Trends in and characteristics of drug overdose deaths involving illicitly manufactured Fentanyls\u2014United States, 2019\u20132020. MMWR Morb Mortal Wkly Rep. 2021;70(50):1740\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"538_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2): e1920622.","journal-title":"JAMA Netw Open"},{"key":"538_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.112389","volume":"263","author":"AR Williams","year":"2024","unstructured":"Williams AR, Mauro CM, Chiodo L, Huber B, Cruz A, Crystal S, et al. Buprenorphine treatment and clinical outcomes under the opioid use disorder cascade of care. Drug Alcohol Depend. 2024;263: 112389.","journal-title":"Drug Alcohol Depend"},{"key":"538_CR6","first-page":"CD002207","volume":"2","author":"RP Mattick","year":"2014","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2:CD002207.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"538_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ADM.0000000000000457","volume":"13","author":"MA Coe","year":"2019","unstructured":"Coe MA, Lofwall MR, Walsh SL. Buprenorphine pharmacology review: update on transmucosal and long-acting formulations. J Addict Med. 2019;13(2):93\u2013103.","journal-title":"J Addict Med"},{"key":"538_CR8","unstructured":"TIP 63: Medications for Opioid Use Disorder [Internet]. 2021 [cited December 12, 2024]. Available from: https:\/\/store.samhsa.gov\/product\/tip-63-medications-opioid-use-disorder\/pep21-02-01-002."},{"issue":"4","key":"538_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/ADM.0000000000001129","volume":"17","author":"JI Tsui","year":"2023","unstructured":"Tsui JI, Stephens D, Collins B, Denisiuk E, Hallgren KA, Blalock KL, et al. Co-use of methamphetamine is associated with lower rates of linkage to outpatient treatment for hospitalized patients who initiate buprenorphine. J Addict Med. 2023;17(4):491\u20132.","journal-title":"J Addict Med"},{"issue":"1","key":"538_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13722-021-00266-2","volume":"16","author":"MC Frost","year":"2021","unstructured":"Frost MC, Lampert H, Tsui JI, Iles-Shih MD, Williams EC. The impact of methamphetamine\/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addict Sci Clin Pract. 2021;16(1):62.","journal-title":"Addict Sci Clin Pract"},{"issue":"3","key":"538_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s11606-016-3919-4","volume":"32","author":"CM Velez","year":"2017","unstructured":"Velez CM, Nicolaidis C, Korthuis PT, Englander H. \u201cIt\u2019s been an Experience, a Life Learning Experience\u201d: a qualitative study of hospitalized patients with substance use disorders. J Gen Intern Med. 2017;32(3):296\u2013303.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"538_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/MLR.0000000000001460","volume":"59","author":"BA Howell","year":"2021","unstructured":"Howell BA, Bart G, Wang EA, Winkelman TNA. Service involvement across multiple sectors among people who use opioids, methamphetamine, or both, United States-2015\u20132018. Med Care. 2021;59(3):238\u201344.","journal-title":"Med Care"},{"key":"538_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jsat.2020.01.010","volume":"112","author":"E Merchant","year":"2020","unstructured":"Merchant E, Burke D, Shaw L, Tookes H, Patil D, Barocas JA, et al. Hospitalization outcomes of people who use drugs: one size does not fit all. J Subst Abuse Treat. 2020;112:23\u20138.","journal-title":"J Subst Abuse Treat"},{"key":"538_CR14","unstructured":"Liu Aw Fau-Yang W-T, Yang Wt Fau-Glick SN, Glick Sn Fau-Kim HN, Kim Hn Fau-Beieler AM, Beieler Am Fau-Lan KF, Lan Kf Fau-Dhanireddy S, et al. Stimulant co-use is associated with patient-directed discharges in hospitalized patients with opioid use and injection drug use related infections (1935\u20133227 (Electronic))."},{"issue":"1","key":"538_CR15","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1186\/s12879-020-05464-y","volume":"20","author":"Y Cai","year":"2020","unstructured":"Cai Y, Dai Z, Wen S, Bhandari R. Risk factors associated with infection of blood-borne virus among people who used methamphetamine. BMC Infect Dis. 2020;20(1):742.","journal-title":"BMC Infect Dis"},{"key":"538_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.drugalcdep.2018.06.017","volume":"190","author":"LMC Nerlander","year":"2018","unstructured":"Nerlander LMC, Hoots BE, Bradley H, Broz D, Thorson A, Paz-Bailey G, et al. HIV infection among MSM who inject methamphetamine in 8 US cities. Drug Alcohol Depend. 2018;190:216\u201323.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"538_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ajad.13115","volume":"30","author":"SN Glick","year":"2021","unstructured":"Glick SN, Klein KS, Tinsley J, Golden MR. Increasing heroin-methamphetamine (Goofball) use and related morbidity among seattle area people who inject drugs. Am J Addict. 2021;30(2):183\u201391.","journal-title":"Am J Addict"},{"issue":"10","key":"538_CR18","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.addbeh.2006.01.003","volume":"31","author":"RA Pollini","year":"2006","unstructured":"Pollini RA, O\u2019Toole TP, Ford D, Bigelow G. Does this patient really want treatment? Factors associated with baseline and evolving readiness for change among hospitalized substance using adults interested in treatment. Addict Behav. 2006;31(10):1904\u201318.","journal-title":"Addict Behav"},{"key":"538_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100031","volume":"2","author":"CD Nordeck","year":"2022","unstructured":"Nordeck CD, Welsh C, Schwartz RP, Mitchell SG, O\u2019Grady KE, Gryczynski J. Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service. Drug Alcohol Depend Reports. 2022;2: 100031.","journal-title":"Drug Alcohol Depend Reports"},{"issue":"8","key":"538_CR20","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","volume":"174","author":"JM Liebschutz","year":"2014","unstructured":"Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369\u201376.","journal-title":"JAMA Intern Med"},{"key":"538_CR21","unstructured":"Stephens D, Collins B, Denisiuk E, Merrill JO, Klein JW, Hallgren K, et al. Methamphetamine use and linkage to outpatient treatment for hospitalized patients who initiate buprenorphine. Addiction Health Services Research Conference; 14 Oct 2021."},{"issue":"1","key":"538_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/08897077.2014.932320","volume":"36","author":"IA Binswanger","year":"2015","unstructured":"Binswanger IA, Whitley E, Haffey PR, Mueller SR, Min SJ. A patient navigation intervention for drug-involved former prison inmates. Subst Abus. 2015;36(1):34\u201341.","journal-title":"Subst Abus"},{"issue":"5","key":"538_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/cid\/ciw806","volume":"64","author":"MM Ford","year":"2017","unstructured":"Ford MM, Johnson N, Desai P, Rude E, Laraque F. From care to cure: demonstrating a model of clinical patient navigation for hepatitis C care and treatment in high-need patients. Clin Infect Dis. 2017;64(5):685\u201391.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"538_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/PHH.0000000000000519","volume":"24","author":"MM Ford","year":"2018","unstructured":"Ford MM, Jordan AE, Johnson N, Rude E, Laraque F, Varma JK, et al. Check Hep C: a community-based approach to hepatitis C diagnosis and linkage to care in high-risk populations. J Public Health Manag Pract. 2018;24(1):41\u20138.","journal-title":"J Public Health Manag Pract"},{"issue":"17","key":"538_CR25","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1097\/QAD.0000000000001987","volume":"32","author":"Y Mizuno","year":"2018","unstructured":"Mizuno Y, Higa DH, Leighton CA, Roland KB, Deluca JB, Koenig LJ. Is HIV patient navigation associated with HIV care continuum outcomes? AIDS. 2018;32(17):2557\u201371.","journal-title":"AIDS"},{"issue":"1","key":"538_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13722-017-0081-1","volume":"12","author":"M Stitzer","year":"2017","unstructured":"Stitzer M, Matheson T, Cunningham C, Sorensen JL, Feaster DJ, Gooden L, et al. Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study. Addict Sci Clin Pract. 2017;12(1):16.","journal-title":"Addict Sci Clin Pract"},{"key":"538_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/08897077.2017.1389802","volume":"39","author":"HE Jack","year":"2017","unstructured":"Jack HE, Oller D, Kelly J, Magidson JF, Wakeman SE. Addressing substance use disorder in primary care: the role, integration, and impact of recovery coaches. Subst Abus. 2017;39:307.","journal-title":"Subst Abus"},{"issue":"1","key":"538_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13722-021-00247-5","volume":"16","author":"JS Tauscher","year":"2021","unstructured":"Tauscher JS, Cohn EB, Johnson TR, Diteman KD, Ries RK, Atkins DC, et al. What do clinicians want? Understanding frontline addiction treatment clinicians\u2019 preferences and priorities to improve the design of measurement-based care technology. Addict Sci Clin Pract. 2021;16(1):38.","journal-title":"Addict Sci Clin Pract"},{"key":"538_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108060","volume":"212","author":"PV AshaRani","year":"2020","unstructured":"AshaRani PV, Hombali A, Seow E, Ong WJ, Tan JH, Subramaniam M. Non-pharmacological interventions for methamphetamine use disorder: a systematic review. Drug Alcohol Depend. 2020;212: 108060.","journal-title":"Drug Alcohol Depend"},{"key":"538_CR30","unstructured":"Aklin WM, Herrmann ES. National Institute on Drug Abuse (NIDA) research priorities to support the development of incentive-based treatments for substance use disorders (1096\u20130260 (Electronic))."},{"issue":"9","key":"538_CR31","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.5588\/ijtld.14.0923","volume":"19","author":"RS Garfein","year":"2015","unstructured":"Garfein RS, Collins K, Munoz F, Moser K, Cerecer-Callu P, Raab F, et al. Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study. Int J Tuberc Lung Dis. 2015;19(9):1057\u201364.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"538_CR32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3201\/eid2203.151620","volume":"22","author":"A Story","year":"2016","unstructured":"Story A, Garfein RS, Hayward A, Rusovich V, Dadu A, Soltan V, et al. Monitoring therapy compliance of tuberculosis patients by using video-enabled electronic devices. Emerg Infect Dis. 2016;22(3):538\u201340.","journal-title":"Emerg Infect Dis"},{"key":"538_CR33","unstructured":"Brooklyn JR, M S, Stunell M, Berman VM, Rylant D, Hanson M, et al. Characterizing the clinical use of a novel video-assisted dosing protocol with secure medication dispensers to reduce barriers to opioid treatment (1935\u20133227 (Electronic))."},{"key":"538_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108896","volume":"143","author":"KA Hallgren","year":"2022","unstructured":"Hallgren KA, Darnton J, Soth S, Blalock KL, Michaels A, Grekin P, et al. Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic. J Subst Abuse Treat. 2022;143: 108896.","journal-title":"J Subst Abuse Treat"},{"key":"538_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108917","volume":"227","author":"JI Tsui","year":"2021","unstructured":"Tsui JI, Leroux BG, Radick AC, Schramm ZA, Blalock K, Labelle C, et al. Video directly observed therapy for patients receiving office-based buprenorphine\u2014a pilot randomized controlled trial. Drug Alcohol Depend. 2021;227: 108917.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"538_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13722-019-0139-3","volume":"14","author":"ME Godersky","year":"2019","unstructured":"Godersky ME, Saxon AJ, Merrill JO, Samet JH, Simoni JM, Tsui JI. Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence. Addict Sci Clin Pract. 2019;14(1):11.","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"538_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/ADM.0000000000000608","volume":"14","author":"ME Godersky","year":"2020","unstructured":"Godersky ME, Klein JW, Merrill JO, Blalock KL, Saxon AJ, Samet JH, et al. Acceptability and feasibility of a mobile health application for video directly observed therapy of buprenorphine for opioid use disorders in an office-based setting. J Addict Med. 2020;14(4):319\u201325.","journal-title":"J Addict Med"},{"key":"538_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108253","volume":"215","author":"EP Bhatraju","year":"2020","unstructured":"Bhatraju EP, Ludwig-Barron N, Takagi-Stewart J, Sandhu HK, Klein JW, Tsui JI. Successful engagement in buprenorphine treatment among hospitalized patients with opioid use disorder and trauma. Drug Alcohol Depend. 2020;215: 108253.","journal-title":"Drug Alcohol Depend"},{"key":"538_CR39","doi-asserted-by":"crossref","unstructured":"Fisher WA, Fisher JD, Harman J. The information-motivation-behavioraI skills model: a general social psychological approach to understanding and promoting health behavior. Social psychological foundations of health and illness. Blackwell series in health psychology and behavioral medicine. Malden: Blackwell Publishing; 2003. p. 82\u2013106.","DOI":"10.1002\/9780470753552.ch4"},{"issue":"1","key":"538_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13722-023-00372-3","volume":"18","author":"JB Darnton","year":"2023","unstructured":"Darnton JB, Bhatraju EP, Beima-Sofie K, Michaels A, Hallgren KA, Soth S, et al. \u201cSign Me Up\u201d: a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic. Addict Sci Clin Pract. 2023;18(1):21.","journal-title":"Addict Sci Clin Pract"},{"key":"538_CR41","doi-asserted-by":"publisher","DOI":"10.2196\/42654","volume":"10","author":"B Idrisov","year":"2023","unstructured":"Idrisov B, Hallgren KA, Michaels A, Soth S, Darnton J, Grekin P, et al. Workload, usability, and engagement with a mobile app supporting video observation of methadone take-home dosing: usability study. JMIR Hum Factors. 2023;10: e42654.","journal-title":"JMIR Hum Factors"},{"issue":"1","key":"538_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13012-019-0891-5","volume":"14","author":"G D\u2019Onofrio","year":"2019","unstructured":"D\u2019Onofrio G, Edelman EJ, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, et al. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH). Implement Sci. 2019;14(1):48.","journal-title":"Implement Sci"},{"issue":"1","key":"538_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","volume":"168","author":"AT McLellan","year":"1980","unstructured":"McLellan AT, Luborsky L, Woody GE, O\u2019Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26\u201333.","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"538_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","volume":"168","author":"AT McLellan","year":"1980","unstructured":"McLellan AT, Luborsky L, Woody GE, O\u2019Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Mental Dis. 1980;168(1):26\u201333.","journal-title":"J Nerv Mental Dis."},{"issue":"4","key":"538_CR45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0149-7189(94)90035-3","volume":"17","author":"NL Weatherby","year":"1994","unstructured":"Weatherby NL, Needle R, Cesari H, Booth R, McCoy CB, Watters JK, et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Eval Prog Plann. 1994;17(4):347\u201355.","journal-title":"Eval Prog Plann"},{"issue":"4","key":"538_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1037\/0893-164X.9.4.242","volume":"9","author":"R Needle","year":"1995","unstructured":"Needle R, Fisher DG, Weatherby N, Chitwood D, Brown B, Cesari H, et al. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav. 1995;9(4):9.","journal-title":"Psychol Addict Behav"},{"issue":"5","key":"538_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"9","key":"538_CR48","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"538_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/09540120050042891","volume":"12","author":"MA Chesney","year":"2000","unstructured":"Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255\u201366.","journal-title":"AIDS Care"},{"issue":"11","key":"538_CR50","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1007\/s10461-016-1406-x","volume":"20","author":"IB Wilson","year":"2016","unstructured":"Wilson IB, Lee Y, Michaud J, Fowler FJ Jr, Rogers WH. Validation of a new three-item self-report measure for medication adherence. AIDS Behav. 2016;20(11):2700\u20138.","journal-title":"AIDS Behav"},{"key":"538_CR51","unstructured":"Bhatraju EP, Radick AC, Leroux BG, Kim TW, Samet JH, Tsui JI. Patterns of buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder. College on Problems of Drug Dependence 84th Annual Scientific Meeting; Submitted; Minneapolis, Minnesota 2022."},{"issue":"2","key":"538_CR52","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"6","key":"538_CR53","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/0962280211427759","volume":"22","author":"GY Zou","year":"2013","unstructured":"Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013;22(6):661\u201370.","journal-title":"Stat Methods Med Res"},{"key":"538_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c869","volume":"340","author":"D Moher","year":"2010","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, G\u00f8tzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340: c869.","journal-title":"BMJ"},{"key":"538_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","volume":"79","author":"P Trowbridge","year":"2017","unstructured":"Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, et al. Addiction consultation services\u2014linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1\u20135.","journal-title":"J Subst Abuse Treat"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00538-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-025-00538-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00538-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T14:53:42Z","timestamp":1738162422000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-025-00538-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1186\/s13722-025-00538-1","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The MIAPP study received approval from the University of Washington\u2019s Institutional Review Board (IRB) in Seattle, Washington. The study follows adverse event reporting procedures required by the National Institute on Drug Abuse (NIDA) and the institution\u2019s IRB. This study is registered at ClinicalTrials.gov (NCT06027814).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}